{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA019466"
        ],
        "brand_name": [
          "DEXTROSE"
        ],
        "generic_name": [
          "DEXTROSE MONOHYDRATE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-7100"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "DEXTROSE MONOHYDRATE"
        ],
        "rxcui": [
          "1795609",
          "1795610",
          "1795616"
        ],
        "spl_id": [
          "477c216c-7446-473a-892d-918faf1dc877"
        ],
        "spl_set_id": [
          "10e98cb0-31a5-4ad1-3eaa-aa4af387a42d"
        ],
        "package_ndc": [
          "0409-7100-68",
          "0409-7100-66",
          "0409-7100-69",
          "0409-7100-67",
          "0409-7100-04",
          "0409-7100-02"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "LX22YL083G"
        ]
      },
      "product_type": "Drugs",
      "event_id": "89100",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA Nationwide",
      "recall_number": "D-0265-2022",
      "product_description": "5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66",
      "product_quantity": "765 bags",
      "reason_for_recall": "Lack of sterility assurance: bag has the potential to leak.",
      "recall_initiation_date": "20211130",
      "center_classification_date": "20211202",
      "termination_date": "20230712",
      "report_date": "20211208",
      "code_info": "Lot: 4923608 Exp. 1MAY2022",
      "more_code_info": ""
    }
  ]
}